ICAD Projected Dividend Yield

iCAD inc ( NASDAQ : ICAD )

iCAD is a medical technology company providing cancer detection and therapy solutions. Co. has two segments: Cancer Detection and Cancer Therapy. In the Cancer Detection segment, Co.'s solutions include image analysis and workflow solutions that enable healthcare personnel to serve patients by identifying pathologies and pinpointing the most prevalent cancers earlier, and a range of Artificial Intelligence and Computer-Aided Detection systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. In the Cancer Therapy segment, Co. provides the Xoft Axxent Electronic Brachytherapy System, an isotope-free cancer treatment platform technology.

20 YEAR PERFORMANCE RESULTS